Casey McPherson
Founder & CEO
AlphaRose Therapeutics
Casey McPherson is an accomplished drug developer, entrepreneur and singer-songwriter based in Austin, Texas. Known for his two #10 US hits, he shifted his focus to rare disease commercial development after his daughter Rose was diagnosed with a rare genetic condition.
In 2020, he founded the To Cure A Rose Foundation and later founded RareLabs, a lab dedicated to developing pre-clinical treatments for rare diseases with 20 programs in the pipeline, and 8 new treatments discovered. In 2023, he launched AlphaRose Therapeutics, a platform to commercialize rare genetic disease therapeutics at scale. Casey continues to build solutions for precision medicine while enjoying life with his two daughters.




